The rise of CRISPR-based therapeutics is becoming increasingly prominent, supported by a series of recent regulatory approvals that validate these cutting-edge approaches within the healthcare industry. Such approvals not only enhance the credibility of CRISPR technologies but also foster a growing confidence among healthcare stakeholders and investors.